Budiodarone

N/A

Report date: 2022/11/25 17:24:08
NME

Base Information

Drug NameBudiodarone
Drug Alias Namebudiodarona布碘达隆布碘酮budiodaronebudiodaronum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockersPotassium channel antagonistsVoltage-gated calcium channel blockers
TargetsPotassium channelSodium channelsVoltage-gated calcium channel
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAryx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAryx Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG